Effect of Topical Application of Tranxamic Acid on reduction of wound drainage and seroma formation after Mastectomy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900022954

Enrollment

Unknown

Registered

2019-05-05

Start date

2018-03-11

Completion date

Unknown

Last updated

2019-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Group I:Topical Tranxamic acid application

Group II:No tranxamic acid used

Eligibility

Sex/Gender

Female

Age

18 Years to 68 Years

Inclusion criteria

Inclusion criteria: 1. women aged 18 years or older; 2. patients with breast carcinoma (ductal or lobular) of any stage; 3. patients for whom MRM had been recommended.

Exclusion criteria

Exclusion criteria: 1. had any history of thromboembolic events; 2. had severe varicose veins, coagulation disorders or receiving anticoagulant drugs; 3. Patients with no measurable drain volume were also excluded.

Design outcomes

Primary

Measure	Time frame
amount of drained fluid;	—

Countries

Egypt

Contacts

Public Contactmahmoud shahin

Faculty of medicine, Menoufia University, Egypt

dr.mshaheen@ymail.com+20 10 06573800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026